readthroughSign in
CompanyLLYNYSEIndianapolis, IN

Eli Lilly

Eli Lilly develops medicines across multiple modalities including biologics and genetic medicine, with programs in diabetes, obesity, Alzheimer's disease, immune disorders, and oncology.

10-QNov 16Latest SEC filing
Nov 16Latest story

November 2026

October 2026

September 2026